跳至主要内容
临床试验/NCT02952638
NCT02952638终止不适用

Dietary Sources of Lysophospholipids

Susan Smyth1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2015年7月14日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
44
试验地点
1
主要终点
Plasma Autotaxin-dependent formation of Lysophosphatidic acid, and Levels of Phosphatidylcholine and its metabolites - Lysophosphatidylcholine, Lysophosphatidic acid, Choline, Trimethylamine and Trimethylamine oxide measured by Tandem Mass Spectrometry

研究概览

简要总结

This study aims to test the hypothesis that dietary intake of phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) acutely alters plasma lysophosphatidic acid (LPA) levels and autotaxin activity in normal weight and obese subjects.

详细描述

Lysophosphatidic acid (LPA) is a simple glycerophospholipid that is found at biologically-relevant levels in plasma and has important effects on isolated or cultured blood, vascular and fat cells. The main enzyme responsible for generation of plasma LPA is the secreted lysophospholipase D, autotaxin (ATX). Adipocytes contribute substantially to plasma ATX levels. The investigators have demonstrated rapid production and metabolism of plasma LPA in animals. More recently, the investigators have observed that plasma LPA levels increase in mice fed a high fat ("Western") diet in comparison to levels found in mice fed normal chow. The investigators have also found that diet-induced obesity increased circulating ATX levels in mice. The investigators hypothesize that diet, and in particular dietary phosphatidylcholine (PC), may regulate the autotaxin substrate lysophosphatidylcholine (LPC), from which LPA is derived. Obesity may amplify the response by increasing plasma ATX levels and/or activity. The current study will test whether dietary PC in normal weight and obese subjects acutely alters LPA levels and autotaxin activity.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 60 years old
  • Body Mass Index of 20 and above
  • Must be able to consume a low fat meal, unlimited fruits and vegetables and not eating after midnight the night before the lipid tolerance test
  • Report to the clinical research unit fasting (no food since the meal the night before)
  • Able to consume a liquid meal consisting of a commercial nutritional product supplemented with fat
  • Able to have an indwelling catheter placed on one arm and have hourly blood draws for 8 hours

排除标准

  • Unstable medical condition (recent or unstable cardiovascular disease)
  • Active cancer
  • Renal insufficiency Glomerular Filtration Rate <30
  • Use of steroids
  • Chronic inflammatory conditions
  • Use of anticoagulants, anti-inflammatory, or lipid-lowering medications
  • Lipodystrophy
  • GI conditions that result in lipid intolerance
  • Pregnant women have a tendency to be anemic and therefore will be excluded.

结局指标

主要结局

Plasma Autotaxin-dependent formation of Lysophosphatidic acid, and Levels of Phosphatidylcholine and its metabolites - Lysophosphatidylcholine, Lysophosphatidic acid, Choline, Trimethylamine and Trimethylamine oxide measured by Tandem Mass Spectrometry

时间窗: 8 hours

Investigators will use tandem mass spectrometry to measure the most abundant metabolite species. Enzymatic activity of autotaxin involves incubation with the substrate lysophosphatidylcholine and monitoring concentration dependent release of lysophosphatidic acid. Levels of Lysophospholipids Phosphatidylcholine and the products of its metabolism in the blood will be measured. Quantitation will be achieved by stable isotope dilution and by reference to offline calibration curves. By using mass spectrometry and metabolic tracers, studies using a common protocol are effectively multiplexed so data on both endogenous and mass labeled lipids can be obtained from a single individual. Given the sensitivity of these analytical methods (limits of quantitation of approximately 1 fmol), the measurements and the quantities will be reported as concentration in picomoles per liter of plasma volume. A statistical correlation with each group based on BMI will be performed.

次要结局

未报告次要终点

研究者

发起方
Susan Smyth
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Susan Smyth

Principal Investigator

University of Kentucky

研究点 (1)

Loading locations...

相似试验